Desflurane

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf inhalational anesthetic
gptkbp:aroma pungent
gptkbp:ATCCode N01AB07
gptkbp:boilingPoint 23.5 °C
gptkbp:brand Suprane
gptkbp:CASNumber 57041-67-5
gptkbp:category general anesthetic
volatile anesthetic
halogenated ether
organofluoride
gptkbp:chemicalFormula C3H2F6O
gptkbp:color colorless
gptkbp:contraindication malignant hyperthermia
known hypersensitivity
gptkbp:density 1.465 g/cm³
gptkbp:discoveredBy gptkb:Ross_Terrell
gptkbp:environmentalImpact high global warming potential
greenhouse gas
gptkbp:excretion exhalation
https://www.w3.org/2000/01/rdf-schema#label Desflurane
gptkbp:introducedIn 1992
gptkbp:IUPACName 2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
gptkbp:KEGGID D07713
gptkbp:legalStatus prescription only
gptkbp:manufacturer gptkb:Baxter_International
gptkb:AbbVie
gptkbp:meltingPoint -44.5 °C
gptkbp:MeSH_ID D019347
gptkbp:metabolism minimal (0.02%)
gptkbp:minimum_alveolar_concentration_(MAC) 6.0% (in adults)
gptkbp:molecularWeight 168.04 g/mol
gptkbp:notRecommendedFor induction in children
patients with airway disease
gptkbp:PubChem_CID 42113
CHEMBL1200712
DB01189
gptkbp:relatedTo gptkb:enflurane
gptkb:isoflurane
sevoflurane
gptkbp:routeOfAdministration inhalation
gptkbp:sideEffect hypotension
respiratory depression
tachycardia
airway irritation
gptkbp:solubility_in_blood_(blood/gas_partition_coefficient) 0.42
gptkbp:solubility_in_oil_(oil/gas_partition_coefficient) 18.7
gptkbp:UNII T8G1HKL98R
gptkbp:used_in operating rooms
gptkbp:usedFor general anesthesia
gptkbp:vapor_pressure_at_20°C 669 mmHg
gptkbp:bfsParent gptkb:Carestation_600_Series
gptkbp:bfsLayer 7